Your account is not claimed yet. You can sign up with ORCID to claim your account.

Jared F Fradette (Jared J Fradette)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

Molecular cancer research : MCR

Oncogene

Cancer research

Cancer prevention research (Philadelphia, Pa.)

This page only lists publications with an associated author ORCID identifier.

Publications

Mabel Perez-Oquendo, Roxsan Manshouri, Yanhua Tian, Jared F Fradette, B Leticia Rodriguez, Samrat T Kundu, Don L Gibbons
ZEB1 is regulated by K811 acetylation to promote stability, NuRD complex interactions, EMT, and NSCLC metastasis. Molecular cancer research : MCR (2023)
Mabel Perez-Oquendo, Roxsan Manshouri, Yanhua Tian, Jared F Fradette, B Leticia Rodriguez, Samrat T Kundu, Don L Gibbons
ZEB1 is Regulated by K811 Acetylation to Promote Stability, NuRD Complex Interactions, EMT, and NSCLC Metastasis. Molecular cancer research : MCR (2023)
Rakhee Bajaj, Amanda N Warner, Jared F Fradette, Don L Gibbons
Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis. Cells 11 (9) (2022)
David H Peng, B Leticia Rodriguez, Lixia Diao, Pierre-Olivier Gaudreau, Aparna Padhye, Jessica M Konen, Joshua Kapere Ochieng, Caleb A Class, Jared F Fradette, Laura Gibson, Limo Chen, Jing Wang, Lauren Averett Byers, Don L Gibbons
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers. Nature communications 12 (1) (2021)
Jessica M Konen, B Leticia Rodriguez, Aparna Padhye, Joshua K Ochieng, Laura Gibson, Lixia Diao, Natalie Wall Fowlkes, Jared F Fradette, David H Peng, Robert J Cardnell, Jeffrey J Kovacs, Jing Wang, Lauren Averett Byers, Don L Gibbons
Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC. Cancer research 81 (5) (2021)
Joshua Kapere Ochieng, Samrat T Kundu, Rakhee Bajaj, B Leticia Rodriguez, Jared F Fradette, Don L Gibbons
MBIP (MAP3K12 binding inhibitory protein) drives NSCLC metastasis by JNK-dependent activation of MMPs. Oncogene 39 (43) (2020)
Rakhee Bajaj, Samrat T Kundu, Caitlin L Grzeskowiak, Jared F Fradette, Kenneth L Scott, Chad J Creighton, Don L Gibbons
IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretion. Oncogene 39 (37) (2020)
David H Peng, Samrat T Kundu, Jared F Fradette, Lixia Diao, Pan Tong, Lauren A Byers, Jing Wang, Jaime Rodriguez Canales, Pamela A Villalobos, Barbara Mino, Yanan Yang, Rosalba Minelli, Michael D Peoples, Christopher A Bristow, Timothy P Heffernan, Alessandro Carugo, Ignacio I Wistuba, Don L Gibbons
ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism. Science translational medicine 11 (483) (2020)
Jose A Monteiro de Oliveira Novaes, Taghreed Hirz, Irene Guijarro, Monique Nilsson, Marlese A Pisegna, Alissa Poteete, Hampartsoum B Barsoumian, Jared F Fradette, Limo N Chen, Don L Gibbons, Xiangjun Tian, Jing Wang, Jeffrey N Myers, Mark J McArthur, Diana Bell, William N William, John Victor Heymach
Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma. Cancer prevention research (Philadelphia, Pa.) 14 (3) (2020)

Jared F Fradette.css-eqlu8i{font-size:small;padding-left:4px;} (Jared J Fradette)

Publication Activity (10 Years)

Top Topics

Top Venues

Jared F Fradette (Jared J Fradette)